DE69602412D1 - Ophthalmische Zubereitung zur Behandlung oder Prävention von trockenem Auge und Krankheiten, die dadurch verursacht werden, enthaltend 12-Sulfodehydroabietsäure - Google Patents

Ophthalmische Zubereitung zur Behandlung oder Prävention von trockenem Auge und Krankheiten, die dadurch verursacht werden, enthaltend 12-Sulfodehydroabietsäure

Info

Publication number
DE69602412D1
DE69602412D1 DE69602412T DE69602412T DE69602412D1 DE 69602412 D1 DE69602412 D1 DE 69602412D1 DE 69602412 T DE69602412 T DE 69602412T DE 69602412 T DE69602412 T DE 69602412T DE 69602412 D1 DE69602412 D1 DE 69602412D1
Authority
DE
Germany
Prior art keywords
dry eye
prevention
treatment
diseases caused
ophthalmic preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69602412T
Other languages
English (en)
Other versions
DE69602412T2 (de
Inventor
Takahiro Ogawa
Noriko Watanabe
Yasushi Okumura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Tanabe Seiyaku Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd, Tanabe Seiyaku Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Publication of DE69602412D1 publication Critical patent/DE69602412D1/de
Application granted granted Critical
Publication of DE69602412T2 publication Critical patent/DE69602412T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69602412T 1995-11-15 1996-11-12 Ophthalmische Zubereitung zur Behandlung oder Prävention von trockenem Auge und Krankheiten, die dadurch verursacht werden, enthaltend 12-Sulfodehydroabietsäure Expired - Lifetime DE69602412T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7322364A JP3059092B2 (ja) 1995-11-15 1995-11-15 ドライアイおよびドライアイを原因とする疾患の予防・治療剤

Publications (2)

Publication Number Publication Date
DE69602412D1 true DE69602412D1 (de) 1999-06-17
DE69602412T2 DE69602412T2 (de) 1999-11-18

Family

ID=18142826

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69602412T Expired - Lifetime DE69602412T2 (de) 1995-11-15 1996-11-12 Ophthalmische Zubereitung zur Behandlung oder Prävention von trockenem Auge und Krankheiten, die dadurch verursacht werden, enthaltend 12-Sulfodehydroabietsäure

Country Status (11)

Country Link
US (1) US5830913A (de)
EP (1) EP0774254B1 (de)
JP (1) JP3059092B2 (de)
KR (1) KR100425354B1 (de)
CN (1) CN1078464C (de)
AT (1) ATE179888T1 (de)
CA (1) CA2190303C (de)
DE (1) DE69602412T2 (de)
ES (1) ES2131373T3 (de)
SG (1) SG42446A1 (de)
TW (1) TW411275B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10045343B4 (de) * 2000-09-14 2005-05-12 Neuhann, Tobias, Dr.med. Verwendung einer wässrigen Lösung oder Suspension zum Heilen des Hornhautepithels
JP4982643B2 (ja) * 2000-09-14 2012-07-25 株式会社林原 眼科用医薬組成物
JP3945625B2 (ja) 2001-03-30 2007-07-18 株式会社イーエムアイ 角膜上皮障害モデル動物及びそのモデル動物を用いた薬剤の評価方法並びにその評価方法を用いて選択された薬剤
US6831101B2 (en) 2001-06-14 2004-12-14 Chemokine Therapeutics Corporation Tricyclic rantes receptor ligands
CN1219757C (zh) * 2001-07-16 2005-09-21 中国医药研究开发中心有限公司 磺化去氢松香酸盐及其制备方法和其用途
KR100606621B1 (ko) * 2001-09-27 2006-07-31 다나베 세이야꾸 가부시키가이샤 에카베트 나트륨 수성 용액 제제
US20040220089A1 (en) * 2001-10-03 2004-11-04 Ellis Edward J. Ophthalmic preparation containing glycoprotein
US20050137166A1 (en) * 2003-12-19 2005-06-23 Alcon, Inc. Use of cooling agents to relieve mild ocular irritation and enhance comfort
CN1956981A (zh) * 2004-05-11 2007-05-02 参天制药株式会社 角膜结膜病变治疗剂
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
US8343942B2 (en) * 2008-04-04 2013-01-01 University Of Utah Research Foundation Methods for treating interstitial cystitis
EP2389939A1 (de) * 2010-05-28 2011-11-30 Novagali Pharma S.A. Verwendung von Prostaglandinen F2alpha und Analoga zur Heilung von Horn- und Bindehautläsionen
US20130209531A1 (en) * 2010-06-08 2013-08-15 University Of Utah Research Foundation Applications of partially and fully sulfated hyaluronan
RU2013117209A (ru) * 2010-11-08 2014-10-27 Хилор Лтд. Буферные глазные композиции и способы их применения
US20120165272A1 (en) * 2010-12-21 2012-06-28 Recopharma Ab Tear Substitutes
KR101438744B1 (ko) * 2012-08-02 2014-09-15 전남대학교산학협력단 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물
EP3831394B1 (de) 2015-01-16 2022-12-21 Seikagaku Corporation Vernetztes chondroitinsulfat, zusammensetzung damit und behandlungsmittel für augenerkrankungen
CN106420797A (zh) * 2016-12-06 2017-02-22 郑州郑先医药科技有限公司 一种治疗干眼病的西药组合及其制备方法
CN106581035A (zh) * 2016-12-06 2017-04-26 郑州郑先医药科技有限公司 一种治疗干眼病的西药组合物
US11229549B2 (en) * 2019-09-18 2022-01-25 Vance M. Thompson Tear transplantation and multi-part contact lens with absorbent portion
CN114588250B (zh) * 2022-03-18 2024-01-09 宁夏杞肽科技有限公司 枸杞糖肽在制备预防或治疗干眼症的药物中的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196554B (it) * 1981-10-22 1988-11-16 Tanabe Seiyaku Co Sale di acido sulfodeidroabietico e composizione farmaceutica che lo contiene
GB2107584A (en) 1981-10-22 1983-05-05 Tanabe Seiyaku Co Treatment of gastro-intestinal diseases
US5545617A (en) * 1993-11-12 1996-08-13 The Schepens Eye Research Institute, Inc. Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion

Also Published As

Publication number Publication date
US5830913A (en) 1998-11-03
ES2131373T3 (es) 1999-07-16
KR970025612A (ko) 1997-06-24
EP0774254A1 (de) 1997-05-21
MX9605633A (es) 1998-05-31
CN1159323A (zh) 1997-09-17
DE69602412T2 (de) 1999-11-18
JP3059092B2 (ja) 2000-07-04
JPH09136832A (ja) 1997-05-27
CN1078464C (zh) 2002-01-30
KR100425354B1 (ko) 2004-06-30
EP0774254B1 (de) 1999-05-12
SG42446A1 (en) 1997-08-15
CA2190303C (en) 2007-01-16
ATE179888T1 (de) 1999-05-15
TW411275B (en) 2000-11-11
CA2190303A1 (en) 1997-05-16

Similar Documents

Publication Publication Date Title
DE69602412D1 (de) Ophthalmische Zubereitung zur Behandlung oder Prävention von trockenem Auge und Krankheiten, die dadurch verursacht werden, enthaltend 12-Sulfodehydroabietsäure
ATE279185T1 (de) 2-amino-2-(2-(4-octylphenyl)ethyl)propan-1,3-di l enthaltendes arzneimittel zur topischen anwendung zur behandlung von erkrankungen die durch eine störung des immunsystems hervorgerufen werden
DE10299034I1 (de) Formulierung zur topischen Anwendung am Auge die olopatadine enthalten zur Behandlung von allergischen Augenerkrankungen
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
DK164441C (da) Anvendelse af et piperidinderivat til fremstilling af et farmaceutisk praeparat til behandling af smertetilstande
DE59508961D1 (de) Verwendung von weihrauch zur behandlung der alzheimer-krankheit
ATE265851T1 (de) Behandlung von erkrankungen, die vom cytokinwachstumsfaktor verursacht werden
DE68904462T2 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelial-gewebekrankheiten.
ATE157871T1 (de) Arzneimittel zur therapeutischen und prophylaktischen behandlung von krankheiten, die durch hyperplasie der glatten muskelzellen bedingt sind
ATE112960T1 (de) Anthocyanidine zur behandlung von augenkrankheiten.
DE69011130T2 (de) Pharmazeutische zusammensetzung bestimmt zur behandlung oder vorbeugung von retroviralen infektionen.
KR930019224A (ko) 유산 위험 치료제
DE68916651T2 (de) Heilmittel zur behandlung von toxoplasmose.
DE68916443D1 (de) Arzneimittel zur behandlung von kryptosporidiose.
DE69428797D1 (de) Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden
NO961496L (no) Behandling av allergiske sykdommer med terfenadinkarboksylat
DE69833317D1 (de) Conagenin zur behandlung von ulzerativer kolitis und/oder morbus crohn
KR890000089A (ko) 신장 질환 치료제

Legal Events

Date Code Title Description
8364 No opposition during term of opposition